Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Cash Flow Reinvestment Rate
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Cash Flow Reinvestment Rate of 1.27x as of September 2025, reinvesting CN¥11.62 Million (capex CN¥11.62 Million ) from operating cash flow of CN¥9.12 Million. Explore capital reinvestment ratio of Shenzhen Bioeasy Biotechnology Co. Ltd. to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shenzhen Bioeasy Biotechnology Co. Ltd. Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Shenzhen Bioeasy Biotechnology Co. Ltd. across 9 annual periods. Also explore 300942 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
Year-by-year capital reinvestment analysis for Shenzhen Bioeasy Biotechnology Co. Ltd.. For live market cap and broader valuation context, see 300942 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | CN¥54.67 Million | CN¥66.87 Million | CN¥45.90 Million | ▼ -87.0% |
| 2024 | 6.28x | CN¥215.23 Million | CN¥34.26 Million | CN¥174.10 Million | ▲ +161.3% |
| 2022 | 2.40x | CN¥366.80 Million | CN¥152.55 Million | CN¥176.85 Million | ▲ +21.4% |
| 2021 | 1.98x | CN¥506.07 Million | CN¥255.42 Million | CN¥79.51 Million | ▼ -19.3% |
| 2020 | 2.46x | CN¥156.65 Million | CN¥63.79 Million | CN¥82.84 Million | ▲ +259.2% |
| 2019 | 0.68x | CN¥45.97 Million | CN¥67.24 Million | CN¥26.29 Million | ▲ +276.1% |
| 2018 | 0.18x | CN¥10.53 Million | CN¥57.93 Million | CN¥10.53 Million | ▼ -60.3% |
| 2017 | 0.46x | CN¥10.82 Million | CN¥23.60 Million | CN¥10.82 Million | ▲ +84.4% |
| 2016 | 0.25x | CN¥9.03 Million | CN¥36.31 Million | CN¥9.03 Million | — |